论文部分内容阅读
肿瘤与糖尿病多数报告认为恶性肿瘤合并糖尿病者多见。Glicksman等研究了628例恶性肿瘤及322例良性肿瘤病人的糖尿病发生率,分别为36.7％和9.3％,前者显著高于后者。但亦有报告并无显著差异。 肿瘤致糖耐量异常的机理目前尚不甚明了。有人利用~(14)C-葡萄糖和~(14)C-软酯酸盐观察肿瘤机体能量代谢的改变,发现癌症病人CO_2产生轻度增加。糖负荷后正常人CO_2产生大都来自投给的葡萄糖,而癌机体由葡萄糖产生的CO_2减少,却以脂肪酸
Most reports of cancer and diabetes that malignant with diabetes are more common. Glicksman et al. Studied the incidence of diabetes in 628 malignant tumors and 322 benign tumor patients, which were 36.7% and 9.3% respectively, the former was significantly higher than the latter. However, there are also no significant differences between the reports. The mechanism of abnormal glucose tolerance in tumor is not clear yet. Some people use ~ (14) C-glucose and ~ (14) C-palmitate observed tumor energy metabolism changes, found that patients with cancer CO 2 increased slightly. After glucose load most of the normal CO 2 production from the vote for glucose, while the cancerous body produced by glucose decreased CO 2, but fatty acids